At Ingenew, we have been expanding our pipeline through business development activities leading to a variety of partnerships, ranging from licensing, acquisition and joint-venture agreements.
Our current business focus is on the following core areas:
- COVID-19
- Oncology
- Drug Delivery Systems
- Dermatology
- Central Nervous System
We offer unique capabilities and expertise that make us the partner of choice in developing promising therapeutics and medical solutions, including:
- Management’s proven track record of technology transfers from academia to industry, from the lab to the cGMP manufacturing facilities;
- Management’s proven track record for win-win deal structure and financial engineering;
- Our scientists’ proven track record in drug development, translational medicine, IND enabling preclinical studies, clinical trial designs and regulatory strategies;
- Access to complementary expertise – academic and institutional network of collaborators;
- Access to commercial infrastructures to enable the marketing of regulatory approved products.